JDM Financial Group »

Perspective Therapeutics shares owned by JDM Financial Group

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by JDM Financial Group from 13F filings

Historical chart of JDM Financial Group investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by JDM Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by JDM Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $12k 3.5k 3.43
2025-06-30 $12k 3.5k 3.44
2025-03-31 $7.5k 3.5k 2.13
2024-12-31 $11k 3.5k 3.19
2024-09-30 $47k 3.5k 13.35

More positions owned by JDM Financial Group

Bny Mellon Us Large Cap Core Equity Etf Etf (BKLC)
Bondbloxx Bloomberg Six Month Target Duration Us Treasury Etf Etf (XHLF)
Vanguard S&p 500 Etf Etf (VOO)
Spdr Portfolio Developed World Ex-us Etf Etf (SPDW)
Ishares S&p 500 Index Etf (IVV)
Vanguard Reit Index Etf Etf (VNQ)
Vanguard Mid Cap Etf (VO)
Vanguard Small-cap Etf Etf (VB)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Spdr Portfolio Emerging Markets Etf Etf (SPEM)
Spdr S&p 500 Etf Trust Etf (SPY)
Apple Stock (AAPL)
Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Spdr Portfolio S&p 500 Value Etf Etf (SPYV)
Spdr Portfolio S&p 500 Etf Etf (SPLG)

View all positions for JDM Financial Group

Top funds holding Perspective Therapeutics

FMR
BlackRock
Vanguard Group
Avidity Partners Management
Millennium Management
Morgan Stanley
Nicholson Wealth Management Group
Geode Capital Management
Nuveen
State Street Corporation
Hills Bank And Trust Company
UBS Group
Walleye Trading Advisors
Charles Schwab Investment Management
Two Sigma Investments

View all funds holding Perspective Therapeutics